U.S. Markets open in 8 hrs 44 mins

Antares Pharma, Inc. (ATRS)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
3.01+0.06 (+2.03%)
At close: 4:00PM EDT
People also watch
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue52,222.04645,658.126,501.665
Cost of Revenue28,816.76619,457.68311,236.695
Gross Profit23,405.2826,200.41715,264.97
Operating Expenses
Research Development21,126.93619,731.56418,638.016
Selling General and Administrative26,394.80426,930.83231,740.249
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-24,116.46-20,461.979-35,113.295
Income from Continuing Operations
Total Other Income/Expenses Net-122.344-21.867-13.42
Earnings Before Interest and Taxes-24,238.804-20,483.846-35,126.715
Interest Expense---
Income Before Tax-24,238.804-20,483.846-35,126.715
Income Tax Expense10017525
Minority Interest---
Net Income From Continuing Ops-24,338.804-20,658.846-35,151.715
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-24,338.804-20,658.846-35,151.715
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-24,338.804-20,658.846-35,151.715